Genomic and Transcriptomic Analysis of Neuroendocrine Transformation in -Rearranged Lung Adenocarcinoma After Treatments With Sequential ALK Inhibitors: A Brief Report.

INTRODUCTION

Neuroendocrine (NE) transformation has been reported in patients with -rearranged NSCLC after ALK inhibition, but unlike -mutant NSCLC, the exact mechanism of NE transformation in -rearranged NSCLC is poorly studied.

METHODS

We collected the matched pre- and post-transformation samples from a patient with -rearranged lung adenocarcinoma (LUAD) and performed targeted panel sequencing, whole exome sequencing, and bulk RNA sequencing.

RESULTS

Multiple mutations were shared between the pretransformation and post-transformation samples. Neither nor mutation was detected, but deletion and amplification were found instead. Mismatch repair-associated mutational signature was significantly enriched after transformation. Genes associated with Notch signaling and PI3K/AKT pathway were significantly up-regulated, whereas genes related to lymphocyte activation and NF-kB signaling were down-regulated. Signatures relating to homologous recombination, mismatch repair, and Notch signaling pathways were enriched, which were further validated in The Cancer Genome Atlas cohorts. Macrophages M2 were found to have prominently higher abundance in the tumor immune microenvironment after NE transformation.

CONCLUSIONS

The mechanism of NE transformation in -rearranged LUAD may be different from that in -mutant LUAD.